Alkem Laboratories has announced that its wholly owned subsidiary, Alkem Medtech Private Limited, has signed a definitive agreement to acquire a 100% stake in Bombay Ortho Industries Private Limited. This acquisition marks a strategic expansion in the company’s portfolio, strengthening its presence in the orthopedic segment.
The Share Purchase and Share Subscription Agreement was executed on March 15, 2025, formalizing the acquisition plan. The deal was initially disclosed in an earlier intimation to the stock exchanges on February 7, 2025.
Alkem Laboratories confirmed that the disclosure regarding this acquisition will be available on its official website in compliance with SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations.
At the time of market closing, shares of Alkem Laboratories were trading at ₹4,681.40, down 1.43% from the previous close of ₹4,749.40.
